SCHEMBL7168641

SCHEMBL7168641

Cc1ccc(C(N)=S)c(N)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
ALOX15 P16050 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
CYP3A4 P08684 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
TP53 P04637 1/20 0.50
THRB P10828 1/20 0.50
HSD17B10 Q99714 1/20 0.50
CA1 P00915 1/20 0.43
HPGD P15428 1/20 0.40
RAD52 P43351 1/20 0.40
GAA P10253 3/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 2/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 1/20 0.38
CYP1A2 P05177 1/20 0.37
MAPT P10636 3/20 0.36
MAPK1 P28482 1/20 0.36
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9770532 0.83 ALOX15 (0.50) ALDH1A1ALOX15TDP1CYP3A4SMN1; SMN2
SCHEMBL10661854 0.83 ALDH1A1 (0.50) ALDH1A1ALOX15TDP1CYP3A4SMN1; SMN2
SCHEMBL10147428 0.80 TDP1 (0.44) ALDH1A1ALOX15TDP1SMN1; SMN2TP53
SCHEMBL8212165 0.78 ALDH1A1 (0.50) ALDH1A1ALOX15TDP1CYP3A4SMN1; SMN2
SCHEMBL10873220 0.78 ALDH1A1 (0.50) ALDH1A1ALOX15TDP1CYP3A4SMN1; SMN2
SCHEMBL160721 0.78 ALDH1A1 (0.50) ALDH1A1ALOX15TDP1CYP3A4SMN1; SMN2
SCHEMBL6897299 0.77 RAB9A (0.47) ALDH1A1ALOX15SMN1; SMN2HPGDRAD52
SCHEMBL6843558 0.77 ALDH1A1 (0.39) ALDH1A1ALOX15HSD17B10HPGDRAD52
SCHEMBL17897876 0.77 ALDH1A1 (0.48) ALDH1A1ALOX15TDP1CYP3A4SMN1; SMN2
SCHEMBL6892362 0.77 ALDH1A1 (0.39) ALDH1A1ALOX15TDP1CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562830-B1 Compounds which prevent or induce the remission of existing precancerous or cancerous lesions or carcinomas would greatly reduce illness and death from cancer CELL PATHWAYS, INC. 2003-05-13 US disclosed
EP-0371731-B1 Quinazolinone derivatives SMITH KLINE FRENCH LAB (GB) 1994-04-20 EP disclosed
US-5147875-A 2-(SUBSTITUTED PHENYL)-4-OXO-QUINAZOLINES SANSHIN KOGYO KABISHIKI KAISHA (JP) 1992-09-15 US disclosed
EP-0371731-A2 Quinazolinone derivatives SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-06-06 EP disclosed